Update in cystic fibrosis 2013.
1 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Manu
M
Jain
Christopher H
CH
Goss
D000627:Aminophenols / Q000627:therapeutic use; D001987:Bronchiectasis / Q000209:etiology; D003550:Cystic Fibrosis / Q000150:complications / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism / Q000503:physiopathology; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics; D019317:Evidence-Based Medicine; D006801:Humans; D008017:Life Expectancy; D009154:Mutation; D018384:Oxidative Stress; D015995:Prevalence; D015363:Quinolones / Q000627:therapeutic use; D018570:Risk Assessment; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects
D000627:Aminophenols; D015363:Quinolones; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; C545203:ivacaftor